{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-024454","form_type":"8-K/A","ticker":"JUNS","cik":"0001679628","company_name":"JUPITER NEUROSCIENCES, INC.","filed_at":"2025-11-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.128605+00:00","generated_at":"2026-05-16T18:05:50.363290+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Jupiter Neurosciences amends SEPA with Yorkville, correcting outstanding shares to 34.3M and Exchange Cap to 6.86M","bullets":["Corrects outstanding shares as of October 24, 2025 from 34,833,083 to 34,294,446.","Corrects Exchange Cap (max shares issuable without stockholder approval) from 7,180,504 to 6,855,459.","SEPA with Yorkville allows up to $20M stock sales; Yorkville advanced $3.72M for first convertible note (principal $4M, 7% OID).","Stockholder meeting scheduled for December 19, 2025 to seek approval to exceed Exchange Cap for additional issuances."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-024454","json":"https://secwatch.observer/filing/0001493152-25-024454.json","markdown":"https://secwatch.observer/filing/0001493152-25-024454.md","text":"https://secwatch.observer/filing/0001493152-25-024454.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1679628/000149315225024454/0001493152-25-024454-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1679628/000149315225024454/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:05:50.363290+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}